Putting NICE guidance into practice. Resource impact report: Hearing loss in adults: assessment and management (NG98)

Similar documents
Putting NICE guidance into practice. Resource impact report: Asthma: diagnosis, monitoring and chronic asthma management (NG80)

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)

Costing Report: atrial fibrillation Implementing the NICE guideline on atrial fibrillation (CG180)

Putting NICE guidance into practice. Resource impact report: ifuse for treating chronic sacroiliac joint pain (MTG39)

Resource impact report: Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27)

Putting NICE guidance into practice. Resource impact report: Obeticholic acid for treating primary biliary cholangitis (TA443)

Putting NICE guidance into practice. Resource impact report: Post-traumatic stress disorder (NG116)

Resource impact report: Eating disorders: recognition and treatment (NG69)

Costing report: Bladder cancer

Costing tool: Osteoarthritis Implementing the NICE guideline on osteoarthritis (CG177)

Resource impact report: Sofosbuvir velpatasvir for treating chronic hepatitis C TA430

Putting NICE guidance into practice

Osteoporosis: fragility fracture risk. Costing report. Implementing NICE guidance

Low back pain and sciatica in over 16s NICE quality standard

Costing statement: Denosumab for the prevention of osteoporotic fractures in postmenopausal women

FREEDOM OF INFORMATION DECISION NOTICE. FOI Reference Number: 999

Freedom of Information

Putting NICE guidance into practice

Costing report. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension. Implementing NICE guidance.

Dementia in England. Dr Charles Alessi Senior Advisor on Dementia, Public Health England

Public consultation: Seeking your views on IVF

NHS public health functions agreement Service specification No.11 Human papillomavirus (HPV) programme

Case scenarios: Patient Group Directions

Cardiac Rehabilitation: Costing Tool Guidance

Costing statement: Atrial fibrillation and heart valve disease: selfmonitoring coagulation status using point-of-care coagulometers (the CoaguChek XS)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)

GOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4

Smoking cessation interventions and services

Report by the Comptroller and. SesSIon January Improving Dementia Services in England an Interim Report

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE

Costing report: Erythropoiesisstimulating

NICE Quality Standards and commissioning dementia care

Chief Dental Officer England: Advice on commercial practice of online registered dental practitioners selling patient group directions for NHS

Alcohol and Drug Commissioning Framework for Northern Ireland Consultation Questionnaire.

Cancer Transformation Programme

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME

FreeStyle Libre for glucose monitoring: Interim Position Statement for GPs & Patient FAQ

POSITION STATEMENT. Diabetic eye screening April Key points

NICE support for commissioning for urinary tract infection in infants, children and young people under 16

Technology appraisal guidance Published: 6 September 2017 nice.org.uk/guidance/ta476

CEO Report 2017/ This report reviews and summarises Healthwatch Cambridgeshire and Peterborough activities for 2017/18.

Technology appraisal guidance Published: 18 July 2018 nice.org.uk/guidance/ta531

Technology appraisal guidance Published: 28 March 2018 nice.org.uk/guidance/ta516

Technology appraisal guidance Published: 30 August 2017 nice.org.uk/guidance/ta472

Extracorporeal shockwave therapy for refractory Achilles tendinopathy

Standard Operating Procedure: Early Intervention in Psychosis Access Times

Surgical management of otitis media with effusion in children

DIRECT ACCESS Guidance to BSDHT Members

DIRECT ACCESS - Guidance to BSDHT Members

NHS England Impact Analysis of implementing NHS Diabetes Prevention Programme, 2016 to 2021

The links between physical health in mental health

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Adult hearing services.

Technology appraisal guidance Published: 21 February 2018 nice.org.uk/guidance/ta507

Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus

Technology appraisal guidance Published: 26 April 2017 nice.org.uk/guidance/ta442

GOVERNING BOARD. Assisted Conception (IVF): Review of access criteria. Date of Meeting 21 January 2015 Agenda Item No 13. Title

LOCSU Community Services. Glaucoma Repeat Readings & OHT Monitoring Community Service Pathway. Issued by Local Optical Committee Support Unit May 2009

2 Summary of NICE TA 249: Atrial fibrillation - Dabigatran Etexilate

Integrated Impact Assessment Report for Clinical Commissioning Policies

British Academy of Audiology Heads of Service Day

Putting NICE guidance into practice

Economic Impact Evaluation Case Study: AliveCor Kardia Mobile

Planning for delivery in 15/16 for the Dementia and IAPT Ambitions

NHS BEXLEY CLINICAL COMMISSIONING GROUP GOVERNING BODY FORMAL MEETING 25 th October 2012

Tier 3 and 4 healthy weight and obesity services in Kent

in North East Lincolnshire Care Trust Plus Implementation Plan Executive Summary

Staying steady. Health & wellbeing. Improving your strength and balance. AgeUKIG14

Integrated Impact Assessment Report for Service Specifications

COT/ BAOT Briefings List

Sexual Health Services (Emergency Hormonal Contraception, Chlamydia Screening, Condom Distribution & Pregnancy Testing) in Pharmacies.

HEALTHWATCH AND HEALTH AND WELLBEING BOARDS

POLICY BRIEFING. Prime Minister s challenge on dementia 2020 implementation plan

Guideline scope Persistent pain: assessment and management

Directed Enhanced Service (DES) for H1N1 Vaccination Programme JCVI priority groups

FINANCE COMMITTEE DEMOGRAPHIC CHANGE AND AGEING POPULATION INQUIRY SUBMISSION FROM NATIONAL OSTEOPOROSIS SOCIETY

BAA. Audiology Services: A Guide for Health Commissioners and Health Boards

A PBC business case for IAPT

NICE update. Paul Chrisp, Programme Director, Medicines and Prescribing Centre

A guide to essential gluten-free foods available from the pharmacy

Audiology in Primary Care - One Year In Evaluation Report

In keeping with the Scottish Diabetes Group criteria, use should be restricted to those who:

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Costing statement: chronic idiopathic constipation - Lubiprostone

Delivering NDPP in a super diverse population

Deep brain stimulation for difficultto-treat

Cheryl Gowar. Date : June 2017

Enhanced Service Specification. Childhood seasonal influenza vaccination programme 2018/19

Technology appraisal guidance Published: 24 January 2018 nice.org.uk/guidance/ta500

Flash Glucose Monitoring (Flash GM) Frequently asked questions (November 2018)

Transplanting donated pancreatic islet cells for patients with type 1 diabetes

Prescription only medicines (POMs)

Enhanced Service Specification. Childhood seasonal influenza vaccination programme 2017/18

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

National Diabetes Treatment and Care Programme

Technology appraisal guidance Published: 24 January 2018 nice.org.uk/guidance/ta499

Prosthetic intervertebral disc replacement in the cervical spine: Cost-effectiveness compared with cervical discectomy with or without vertebral

Community alcohol detoxification in primary care

Lincolnshire JSNA: Cancer

Audit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57)

Transcription:

Putting NICE guidance into practice Resource impact report: Hearing loss in adults: assessment and management (NG98) Published: June 2018

Summary This report focuses on the recommendation from NICE s guideline on Hearing loss that we think will have the greatest resource impact nationally (for England), and will need the most additional resources to implement. It is: Refer adults who present with hearing difficulties for a hearing assessment. Implementing the guideline is expected to lead to the following additional costs: Hearing assessments, for people not currently referred to audiology. Additional hearing aids, including fitting and follow up. The estimated annual cost of implementing this guideline per 100,000 population based on the resource impact assumptions is shown in table 1. For England, this is equivalent to costs in the first 5 years of 2.6m (2018/19), 5.2m (2019/20), 10.3m (2020/21), 15.5m (2021/22) and 20.7m (2022/23). Table 1 Estimated annual cost of implementing the guideline for a population of 100,000 Cost impact each year of implementing the hearing loss guideline 2018/19 2019/20 2020/21 2021/22 2022/23 4,713 9,425 18,851 28,276 37,702 This report is supported by a resource impact template which may be used to calculate the resource impact of implementing the guidance by amending the variables. Services for people with hearing loss are commissioned by clinical commissioning groups (CCGs). Providers are NHS hospital trusts, community providers (in some parts of England this is through the Any Qualified Provider (AQP) scheme) and primary care. (June 2018) 2 of 13

1 Introduction 1.1 The guideline offers best practice advice on hearing loss in adults. 1.2 This report discusses the resource impact of implementing our guideline on Hearing loss in adults: assessment and management in England. It aims to help organisations plan for the financial implications of implementing this NICE guideline. 1.3 A resource impact template accompanies this report to help with assessing the resource impact at a local level in England, Wales or Northern Ireland. 1.4 We have considered direct costs and savings to the NHS and not those for the individual, the private sector or the not-for-profit sector. 1.5 Services for people with hearing loss are commissioned by clinical commissioning groups (CCGs). Providers are NHS hospital trusts, community providers (in some parts of England this is through the Any Qualified Provider (AQP) scheme) and primary care. 2 Background 2.1 Hearing loss affects over 9 million adults in England. The NHS England Action plan on hearing loss identifies the need for improved early identification of hearing loss and early treatment. It is estimated in the Hearing Matters paper from Action on Hearing Loss that 5.6 million adults in England would benefit from having a hearing aid. There are estimated to be around 3 million adults in England who already have hearing aids. 2.2 There are 2 population groups where there is a potential resource impact: people with hearing difficulties presenting to healthcare professionals for the first time who are not currently referred to audiology services and people in the general population who have (June 2018) 3 of 13

hearing loss, who have not previously been referred (for hearing aids). Section 3.1 of this report and the resource impact template focus on people presenting to services for the first time. People in the general population with hearing loss who have not been referred (for hearing aids) are addressed in the sensitivity analysis since the potential resource impact is less certain. 3 Significant resource impact recommendation 3.1 Recommendation 1.1.1 Background For adults who present for the first time with hearing difficulties, or in whom you suspect hearing difficulties: exclude impacted wax and acute infections such as otitis externa, then arrange an audiological assessment (for more information on audiological assessment see recommendation 1.5.1) and refer for additional diagnostic assessment if needed (see recommendations 1.1.2 to 1.1.7 on sudden or rapid onset of hearing loss and hearing loss with specific additional symptoms or signs). 3.1.1 There are around 896 people per 100,000 population who present to healthcare professionals with hearing difficulties, not explained by impacted wax and acute infection, each year. This is equivalent to around 491,000 people in England. Currently only 73% of these people go on to have hearing assessments. This recommendation will increase the number of people being referred for a hearing assessment. 3.1.2 There are a significant number of people who currently have hearing loss and have not presented to healthcare professionals (June 2018) 4 of 13

with hearing difficulties. The potential resource impact of some of these people being identified and referred is assessed in the sensitivity analysis. Assumptions made 3.1.3 It is estimated that each year around 896 people per 100,000 present to healthcare professionals with hearing difficulties, not explained by impacted wax and acute infection. This is extrapolated from the NHS reference costs activity 2016/17 for hearing assessments of adults in audiology services, including community health services. 3.1.4 Of people who present to a healthcare professional with hearing difficulties, 73% are currently referred for a hearing assessment (Benova, L. et al 2015). 3.1.5 When this guideline is fully implemented, it is anticipated that the 27% of people who present to a healthcare professional with hearing difficulties, but are currently not referred for hearing assessment, will be referred. This is based on clinical expert opinion. 3.1.6 Of the people with hearing difficulties who are referred following the implementation of this guideline, and who previously would not have been referred, 95% will attend the hearing assessment, based on clinical expert opinion. 3.1.7 Around 56% of people who have a hearing assessment will be recommended a hearing aid. This is the same in the template for both current and future practice. 3.1.8 Around 90% of people who have hearing loss and would benefit from hearing aids will go on to have hearing aids. People decline hearing aids, following assessment, in around 10% of cases, based on clinical expert opinion. (June 2018) 5 of 13

3.1.9 People who are fitted with hearing aids are fitted with 2 hearing aids in around 85% of cases (NHS England commissioning framework). The other 15% will have one hearing aid fitted. 3.1.10 By 2022/23 80% of the 27% of people who present each year to healthcare professionals, currently not being referred, will be referred for hearing assessments, based on clinical expert opinion, as shown in table 2. 3.1.11 The costs over time are estimated on the basis of the guideline uptake over the first 5 years, as shown in table 2. Table 2 Rate of implementation of the guideline in the first 5 years Year 2018/19 2019/20 2020/21 2021/22 2022/23 Rate of implementation 10% 20% 40% 60% 80% 3.1.12 There may be additional activity from community services that is not recorded and captured in this analysis. It is not anticipated that there will be an additional resource impact relating to this activity as a result of implementing the guideline. Costs 3.1.13 The resource impact of this recommendation is due to the additional cost of people who present with hearing difficulties being referred for a hearing assessment and more people having hearing aids fitted. The unit costs of assessments, fitting, device and follow up are based on the 2016/17 non mandatory national tariff, details are shown in table 3. (June 2018) 6 of 13

Table 3 Costs of hearing assessment, hearing aid fitting, device and follow up Description Cost Hearing aid assessment only 53 Pathway for assessment, fitting 1 hearing aid device, cost of 1 hearing aid device and first follow up Pathway for assessment, fitting 2 hearing aid devices, cost of 2 hearing aid devices first follow up 268 370 3.1.14 The net cost of referring adults who present with hearing difficulties for hearing assessment and hearing aid fitting is summarised in table 4. Table 4 Estimated annual incremental cost of referring adults who present with hearing difficulties for hearing assessment and hearing aid fitting and the number of people affected per 100,000 population 2018/19 2019/20 2020/21 2021/22 2022/23 Number of people who have a hearing assessment only Number of people who have a hearing assessment and have hearing aids fitted Cost impact each year for additional people needing hearing assessment only Cost impact each year for additional people having a hearing assessment and having hearing aids fitted, including testing and follow up Total resource impact 336 347 370 393 416 341 353 376 399 422 604 1,208 2,417 3,625 4,833 4,109 8,217 16,434 24,651 32,869 4,713 9,425 18,851 28,276 37,702 Benefits and savings 3.1.15 Research shows that hearing loss doubles the risk of developing depression and increases the risk of anxiety and other mental health (June 2018) 7 of 13

issues. Research also suggests that use of hearing aids reduces these risks. 3.1.16 Action on Hearing Loss s Access all areas report estimates that 1 in 7 people with hearing loss have missed a healthcare appointment while being in the waiting room. Implementing the guideline should reduce the number of these missed appointments, improving services efficiency. 3.1.17 Hearing loss has a significant impact on individuals, leading to difficulty with communication at work, socially and at home. This can affect family relationships, employment or educational opportunities, enjoyment of leisure pursuits and independence. Hearing loss can cause feelings of isolation and low self-esteem and can lead to a significant reduction in people s quality of life. Hearing aids can improve communication for these people. 3.1.18 There is an association between hearing loss and cognitive performance as well as dementia. This association is more marked with severe hearing loss. 3.1.19 Implementing the guideline should help people with hearing aids have more success using their hearing aids. This may reduce the number of audiology appointments that they need. 4 Resource impact over time 4.1 The estimated annual cost of implementing this guideline per 100,000 population based on the uptake in the resource impact assumptions is shown in table 5. For England, this is equivalent to costs in the first 5 years of 2.6m (2018/19), 5.2m (2019/20), 10.3m (2020/21), 15.5m (2021/22) and 20.7m (2022/23). (June 2018) 8 of 13

Table 5 Resource impact of implementing the guideline using NICE assumptions for a population of 100,000 Cost impact each year of implementing the hearing loss guideline 2018/19 2019/20 2020/21 2021/22 2022/23 4,713 9,425 18,851 28,276 37,702 5 Other considerations 5.1 Hearing aids are available in the private sector. There is the possibility that making hearing tests and hearing aids more available may result in additional costs for the NHS that are not captured in this report and template. 6 Implications for commissioners 6.1 Hearing loss falls under programme budgeting category 09X problems of hearing. 6.2 It is anticipated that there will be additional costs for commissioners as a result of the increase in hearing assessments and hearing aids fitted. 6.3 Prices for hearing assessment and hearing aid provision are agreed at a local level. Commissioners are advised to adjust the resource impact template to reflect local circumstances. 7 Sensitivity analysis 7.1 There are some assumptions in the model for which no empirical evidence exists, so we cannot be as certain about them. Appropriate minimum and maximum values of variables were used in the sensitivity analysis to assess which variables have the biggest impact on the net cost or saving. This enables users to identify the significant cost drivers. (June 2018) 9 of 13

Appendix A is a table listing all variables modified for the people presenting to services for the first time. The key conclusions are discussed below. 7.2 The resource impact is very sensitive to the rate of uptake of the guideline. The rate of uptake is based on clinical expert opinion and will be dependent on local circumstances. 7.3 The number of people who accept hearing aids after being recommended them based on the results of a hearing test is based on clinical expert opinion. The resource impact is also sensitive to this variable. 7.4 It is assumed in the base case that there will be no uptake in the prevalent population (the general population with hearing loss, excluding those presenting to healthcare professionals with hearing difficulties). If there were to be some uptake in the prevalent population that have hearing difficulties and may need a hearing aid this would be an additional resource impact. 7.5 There are 2 additional scenarios that are explored in the sensitivity analysis. Both look at the general population who may benefit from a hearing aid but currently do not have one. The additional cost of hearing tests and hearing aids is highlighted in table 6. 7.6 Further information of the assumptions used for the general population can be found within the Prevalent sensitivity worksheet in the resource impact template. (June 2018) 10 of 13

Table 6 Resource impact over time of uptake in the prevalent population who would benefit from a hearing aid but currently do not have one, per 100,000 population 5% uptake over 5 years in people in the general population who have hearing loss, who have not previously been referred for a hearing assessment 10% uptake over 5 years in people in the general population who have hearing loss, who have not previously been referred for a hearing assessment 2018/19 2019/20 2020/21 2021/22 2022/23 5,468 6,066 7,265 8,462 9,259 10,843 11,946 14,154 16,361 18,455 7.7 Assuming there is 5% uptake in the general population with hearing loss over a 5 year period leads to an additional cost in 2022/23 of 9,259 per 100,000 population. This is equivalent to around 5.1 million for England. 7.8 Assuming there is 10% uptake in the general population with hearing loss over a 5 year period leads to an additional cost in 2022/23 of 18,455 per 100,000 population. This is equivalent to around 10.1 million for England. (June 2018) 11 of 13

Appendix A. Results of sensitivity analysis Individual variable sensitivity Baseline value Minimum value Maximum value Recurrent resource impact Minimum resource impact ( s) Baseline resource impact ( s) Maximum resource impact ( s) Change ( s) Sensitivity ratio Uptake of recommendation at 2022/23 80.00% 70.00% 90.00% 37,702 33,593 41,811 8,218 0.87 People who are recommended a hearing aid 56.00% 41.00% 71.00% 37,702 30,213 45,191 14,978 0.74 People who accept a hearing aid following being recommended a hearing aid 90.00% 85.00% 95.00% 37,702 36,149 39,255 3,106 0.74 Proportion of people who are offered 2 hearing aids 85.00% 75.00% 95.00% 37,702 36,757 38,647 1,890 0.21 (June 2018) 12 of 13

About this resource impact report This resource impact report accompanies the NICE guideline on Hearing loss in adults: assessment and management and should be read in conjunction with it. See terms and conditions on the NICE website. NICE 2018. All rights reserved. See Notice of rights. (June 2018) 13 of 13